Venture Capital Investors
Boryung Pharmaceutical
Boryung Pharmaceutical is a VC fund that invests in companies focused on high-impact, technology-driven solutions.
Venture Investor Overview
Venture Investor
Boryung Pharmaceutical
Investor Type
Venture Capital
Industry Focus
Transportation
Contact Information
Title
Chief Executive Officer
Mailing Address
136, Changgyeonggung-ro
Jongno-gu, Seoul, 03127
KR
Background Information
Overview
Aiming to make 2022 the year of another leap forward by identifying new opportunities and encouraging investment, we changed our corporate name from Boryung Pharmaceutical to Boryung Corp. at our general shareholders' meeting on March 25, 2022. The new CI was also introduced to demonstrate Boryung's identity that pursues greater value and going beyond a leader in the domestic pharmaceutical industry. The history of Boryung began in 1957 with the opening of the Boryung Pharmacy in Jongno 5-ga, based on the spirit of the founder Kim Seung-ho, who used to ride his bicycle around the city to get medicines for sick people no matter how hard they were to find.
Last Transaction
8/21/2023
Transaction History
Our records indicate that Boryung Pharmaceutical invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.
8/21/2023
Series C
$350,000,000
Investor Contacts
Chief Executive Officer
Daniel Chang
Funds
No fund closings have been recorded for this company.
Portfolio Companies
Boryung Pharmaceutical has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.
Browse more venture capital investors:
Borski Fund | Bosch Holding
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs